Clinical utility of BRAF-targeted therapy in melanoma | ПРЕЦИЗИОННАЯ ОНКОЛОГИЯ

Clinical utility of BRAF-targeted therapy in melanoma

BRAF targets in melanoma. Biological mechanisms, resistance, and drug discovery. Cancer drug discovery and development. Volume 82. Ed. Ryan J. Sullivan. Springer (2015)


  1. Introduction
  2. BRAF inhibitors
  3. MEK inhibitors
  4. Combination therapy
  5. Special clinical situations
  6. Conclusion and future directions
  7. References

[contact-form-7 id=»5168″ title=»Контактная форма 1″]

0